Readit NewsA pertinent quote from the article (which is a really nice read, I'd recommend reading it fully at least once):
> Previous Opus 4 models were barely capable of producing a functional compiler. Opus 4.5 was the first to cross a threshold that allowed it to produce a functional compiler which could pass large test suites, but it was still incapable of compiling any real large projects. My goal with Opus 4.6 was to again test the limits.
Oversimplifying:
X = full amount of raised capital
Y = expected spend over 12 months
Z = $ value of percentage contingency for 12 months
Y+Z goes into use-it-however-and-whenever-you-want account (likely low to no interest)
X - (Y+Z) goes into a 12 month higher interest account, ideally staying untouched until maturity (stake the stablecoins in this context)
I'm skeptical of crpyto holding companies though, explicitly because of the lack of regulation. The likes of BlockFi, Celsius, and FTX gives me the cold sweats. Regulation in the US is notoriously lacking even in well established finance and banking, never mind the crypto 'industry' which was always high-percentage grifters, and now the Epstein files has added 'morally corrupt' tags to more of them.
Recipe for sleepless nights, which is already a problem for a startup founders isn't it?
Also X=Y for almost all startups.
The particular complaint of "cannot state compounded drugs use the same active ingredient" is weird but if it only applies to marketing then sure crack down on that too.